Alvaro Lladser

12PUBLICATIONS
31CO-AUTHORS
Haematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review.

|Jun 25, 2026
Early neutrophil infiltration promotes TRIMELVax-induced antitumor immunity by linking local inflammation to tumor control.

|Mar 30, 2026
Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models.

Diego Figueroa, Juan Pablo Vega, Andrés Hernández-Oliveras

|Mar 13, 2026
Contrasting functions of CD73 and adenosine in CD8+ T-cell exhaustion during antitumor immunity.

Juan Saavedra-Almarza, Solange Gouët, Felipe Malgue

|Jan 11, 2026
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.

Pablo Morgado-Cáceres, Francisca Hofmann-Vega, Diego Figueroa

|Oct 16, 2024
Unraveling the Role of JMJD1B in Genome Stability and the Malignancy of Melanomas.

Perla Cruz, Diego Peña-Lopez, Diego Figueroa

Pageof 2

Frequent Collaborators

2 joint publications

Felipe Gálvez-Cancino

2 joint publications

Flavio Salazar-Onfray

2 joint publications

Diego Figueroa

2 joint publications

María Alejandra Gleisner